A detailed history of State Board Of Administration Of Florida Retirement System transactions in Exelixis, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 372,972 shares of EXEL stock, worth $14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
372,972
Previous 387,938 3.86%
Holding current value
$14 Million
Previous $10.1 Million 23.38%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$25.39 - $36.46 $379,986 - $545,660
-14,966 Reduced 3.86%
372,972 $12.4 Million
Q3 2024

Nov 08, 2024

BUY
$21.96 - $27.6 $1.72 Million - $2.17 Million
78,543 Added 25.39%
387,938 $10.1 Million
Q2 2024

Aug 08, 2024

SELL
$20.34 - $23.73 $211,515 - $246,768
-10,399 Reduced 3.25%
309,395 $6.95 Million
Q1 2024

May 08, 2024

BUY
$20.17 - $23.93 $209,747 - $248,848
10,399 Added 3.36%
319,794 $7.59 Million
Q4 2023

Feb 09, 2024

BUY
$19.25 - $24.13 $365 - $458
19 Added 0.01%
309,395 $7.42 Million
Q3 2023

Nov 08, 2023

BUY
$19.04 - $22.74 $9,139 - $10,915
480 Added 0.16%
309,376 $6.76 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $198,016 - $223,191
-10,898 Reduced 3.41%
308,896 $5.9 Million
Q1 2023

Jun 14, 2023

BUY
$16.3 - $19.41 $6,161 - $7,336
378 Added 0.12%
319,794 $6.21 Million
Q1 2023

May 11, 2023

BUY
$16.3 - $19.41 $6,161 - $7,336
378 Added 0.12%
319,794 $6.21 Million
Q4 2022

Jun 14, 2023

SELL
$14.96 - $17.39 $5,654 - $6,573
-378 Reduced 0.12%
319,416 $5.12 Million
Q4 2022

Feb 07, 2023

SELL
$14.96 - $17.39 $262,697 - $305,368
-17,560 Reduced 5.21%
319,416 $5.12 Million
Q2 2022

Aug 05, 2022

SELL
$17.44 - $23.16 $143,095 - $190,027
-8,205 Reduced 2.38%
336,976 $7.02 Million
Q1 2022

May 06, 2022

SELL
$17.03 - $22.67 $2.17 Million - $2.89 Million
-127,625 Reduced 26.99%
345,181 $7.83 Million
Q4 2021

Feb 08, 2022

BUY
$15.84 - $21.88 $1.95 Million - $2.69 Million
122,923 Added 35.13%
472,806 $8.64 Million
Q3 2021

Nov 08, 2021

SELL
$16.3 - $21.14 $69,112 - $89,633
-4,240 Reduced 1.2%
349,883 $7.4 Million
Q1 2021

May 10, 2021

SELL
$20.53 - $25.22 $1.14 Million - $1.4 Million
-55,657 Reduced 13.58%
354,123 $8 Million
Q4 2020

Feb 08, 2021

BUY
$18.39 - $24.8 $426,225 - $574,789
23,177 Added 6.0%
409,780 $8.22 Million
Q3 2020

Nov 09, 2020

SELL
$20.67 - $26.94 $1.14 Million - $1.48 Million
-55,003 Reduced 12.46%
386,603 $9.45 Million
Q2 2020

Aug 07, 2020

SELL
$16.46 - $27.42 $411,022 - $684,704
-24,971 Reduced 5.35%
441,606 $10.5 Million
Q1 2020

May 05, 2020

SELL
$14.46 - $21.8 $152,148 - $229,379
-10,522 Reduced 2.21%
466,577 $8.03 Million
Q4 2019

Feb 03, 2020

BUY
$15.15 - $18.89 $320,074 - $399,089
21,127 Added 4.63%
477,099 $8.41 Million
Q3 2019

Nov 07, 2019

SELL
$17.68 - $22.65 $40,275 - $51,596
-2,278 Reduced 0.5%
455,972 $8.06 Million
Q2 2019

Aug 05, 2019

BUY
$18.93 - $24.75 $14,367 - $18,785
759 Added 0.17%
458,250 $9.79 Million
Q1 2019

May 03, 2019

SELL
$19.6 - $24.76 $164,346 - $207,612
-8,385 Reduced 1.8%
457,491 $10.9 Million
Q4 2018

Feb 01, 2019

BUY
$13.65 - $21.8 $1 Million - $1.6 Million
73,442 Added 18.71%
465,876 $9.16 Million
Q2 2018

Aug 06, 2018

BUY
$18.56 - $22.45 $98,739 - $119,434
5,320 Added 1.37%
392,434 $8.45 Million
Q1 2018

May 04, 2018

SELL
$22.15 - $31.89 $37,655 - $54,213
-1,700 Reduced 0.44%
387,114 $8.58 Million
Q4 2017

Feb 01, 2018

BUY
$24.23 - $30.93 $103,389 - $131,978
4,267 Added 1.11%
388,814 $11.8 Million
Q3 2017

Oct 31, 2017

BUY
$23.35 - $29.24 $8.98 Million - $11.2 Million
384,547
384,547 $9.32 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.1B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.